Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro
- PMID: 31252
- PMCID: PMC1537567
Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro
Abstract
Comparative analysis of the systemic immunity revealed similarities between ulcerative colitis and idiopathic proctitis. In the active stage of both diseases, circulating complement receptor positive cells were increased whereas T-cell percentages and lymphocyte functions were decreased. In severe forms of ulcerative colitis and idiopathic proctitis circulating EAC-phagocytosing esterase positive cells, indicative of activated monocytes, were demonstrated. Successful treatment with salicylazosulfapyridine (SASP) reversed these immunological changes. Incubation of SASP and its metabolites with leucocytes from patients and control subjects, in concentrations similar to those demonstrated in sera from patients treated with SASP, did not alter the immunological changes.
Similar articles
-
Maintenance oral sulfasalazine prolongs remission in ulcerative proctitis and proctosigmoiditis.Am J Gastroenterol. 1991 Oct;86(10):1456-60. Am J Gastroenterol. 1991. PMID: 1681725
-
[Rectal effect of salazopyrine in ulcerative colitis during a double-blind study].Wien Z Inn Med. 1973;54(4):185-9. Wien Z Inn Med. 1973. PMID: 4148682 Clinical Trial. German. No abstract available.
-
[Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].Zhonghua Yi Xue Za Zhi. 2002 Mar 25;82(6):384-8. Zhonghua Yi Xue Za Zhi. 2002. PMID: 11953203 Chinese.
-
Drug therapy: Sulfasalazine.N Engl J Med. 1975 Jul 3;293(1):20-3. doi: 10.1056/NEJM197507032930105. N Engl J Med. 1975. PMID: 236516 Review. No abstract available.
-
Current status of drug therapy for inflammatory bowel disease.Compr Ther. 1985 Dec;11(12):14-9. Compr Ther. 1985. PMID: 2866866 Review.
Cited by
-
Effects of sulfasalazine on selected lymphocyte subpopulations in vivo and in vitro.Dig Dis Sci. 1979 Sep;24(9):672-9. doi: 10.1007/BF01314463. Dig Dis Sci. 1979. PMID: 39716
-
Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.Rheumatol Int. 1985;5(6):247-51. doi: 10.1007/BF00541351. Rheumatol Int. 1985. PMID: 2906452
-
Antihelper T cell autoantibody in acquired agammaglobulinemia.J Clin Invest. 1981 Jan;67(1):42-50. doi: 10.1172/JCI110031. J Clin Invest. 1981. PMID: 6450224 Free PMC article.
-
Inflammatory intermediaries in inflammatory bowel disease.Int J Colorectal Dis. 1989;4(2):75-90. doi: 10.1007/BF01646865. Int J Colorectal Dis. 1989. PMID: 2664059 Review. No abstract available.
-
Sulphasalazine in rheumatoid arthritis: an old drug revived.J R Soc Med. 1984 Mar;77(3):169-72. doi: 10.1177/014107688407700301. J R Soc Med. 1984. PMID: 6142116 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources